• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

劳力性心绞痛患者对硝酸异山梨酯抗心绞痛作用耐受性的产生与逆转

The development and reversal of tolerance to antianginal effect of isosorbide dinitrate in patients with effort angina.

作者信息

Toyosaki N, Katsuki T, Fujii M, Kawada Y, Komaba A, Watabiki H, Hasegawa H, Suzuki S, Natsume T, Yaginuma T

机构信息

Department of Cardiology, Jichi Medical School, Tochigi, Japan.

出版信息

Jpn Circ J. 1989 May;53(5):395-405. doi: 10.1253/jcj.53.395.

DOI:10.1253/jcj.53.395
PMID:2769927
Abstract

The development and reversal of tolerance to the hemodynamic and anti-anginal effects of isosorbide dinitrate in a sustained release form (ISDN-SR) were investigated in 11 male patients (mean age 58.9 y.o.) with stable effort angina. Treadmill exercise test, evaluation of hemodynamic parameters and measurement of plasma ISDN concentrations were performed during the control period, on the 1st, 7th and 14th days of therapy with 40 mg of ISDN-SR orally every 8 h and, subsequently, on the day when ISDN-SR was re-administered after a 72 h placebo period (17th day). Initially, exercise tolerance time (ETT) was prolonged significantly (p less than 0.001) by ISDN-SR from 257 +/- 50 sec in the control period to 434 +/- 55 sec on day 1. This prolongation was significantly reduced with sustained therapy and ETT was shortened to 332 +/- 69 sec on the 7th day (p less than 0.01 vs day 1) and 326 +/- 73 sec on the 14th day (p less than 0.01 vs day 1). The effects of ISDN-SR initially observed were restored after a 72 h placebo period and ETT was prolonged to 432 +/- 57 sec on the 17th day. The resting heart rate was increased significantly (p less than 0.01 vs control) and systolic blood pressure was decreased (p less than 0.001 vs control) by ISDN-SR on day 1. These changes were also diminished significantly (p less than 0.01 vs day 1) with sustained therapy and were restored after a 72 h nitrate-free interval.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在11名患有稳定劳力性心绞痛的男性患者(平均年龄58.9岁)中,研究了对缓释型硝酸异山梨酯(ISDN-SR)血流动力学和抗心绞痛作用耐受性的发展及逆转情况。在对照期、每8小时口服40毫克ISDN-SR治疗的第1天、第7天和第14天,以及随后在72小时安慰剂期后重新给予ISDN-SR的当天(第17天),进行了平板运动试验、血流动力学参数评估和血浆ISDN浓度测量。最初,ISDN-SR使运动耐受时间(ETT)显著延长(p<0.001),从对照期的257±50秒延长至第1天的434±55秒。持续治疗后这种延长显著减少,ETT在第7天缩短至332±69秒(与第1天相比p<0.01),在第14天缩短至326±73秒(与第1天相比p<0.01)。72小时安慰剂期后,最初观察到的ISDN-SR的作用得以恢复,第17天ETT延长至432±57秒。第1天,ISDN-SR使静息心率显著增加(与对照相比p<0.01),收缩压降低(与对照相比p<0.001)。持续治疗后这些变化也显著减弱(与第1天相比p<0.01),并在72小时无硝酸盐间隔后恢复。(摘要截短于250字)

相似文献

1
The development and reversal of tolerance to antianginal effect of isosorbide dinitrate in patients with effort angina.劳力性心绞痛患者对硝酸异山梨酯抗心绞痛作用耐受性的产生与逆转
Jpn Circ J. 1989 May;53(5):395-405. doi: 10.1253/jcj.53.395.
2
[Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
Przegl Lek. 2000;57(9):455-8.
3
Tolerance to isosorbide dinitrate: rate of development and reversal.硝酸异山梨酯耐受性:发展速率与逆转情况
Circulation. 1983 Nov;68(5):1074-80. doi: 10.1161/01.cir.68.5.1074.
4
[Tolerance to a sustained release form of isosorbide dinitrate: comparison between 20 mg four times and 40 mg twice-daily administrations].
Kokyu To Junkan. 1991 Sep;39(9):925-30.
5
[Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
Herz. 1985 Jun;10(3):163-71.
6
[Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].[口服硝酸异山梨酯治疗稳定型心绞痛患者不同阶段个体硝酸酯类药物耐受性的发展]
Pol Merkur Lekarski. 2002 Jul;13(73):52-5.
7
Short and long-acting oral nitrates for stable angina pectoris.用于稳定型心绞痛的短效和长效口服硝酸盐类药物。
Cardiovasc Drugs Ther. 1994 Aug;8(4):611-23. doi: 10.1007/BF00877415.
8
[Plasma volume expansion may explain the attenuation of antianginal activity of oral isosorbide dinitrate in long-term therapy].
Pol Arch Med Wewn. 1999 Nov;102(5):967-72.
9
Development of nitrate tolerance and usefulness of pulse therapy in a patient with vasospastic angina.血管痉挛性心绞痛患者硝酸酯类药物耐受性的发展及脉冲疗法的效用
Eur Heart J. 1992 Jun;13(6):853-5. doi: 10.1093/oxfordjournals.eurheartj.a060270.
10
Sustained antianginal efficacy of oral high-dose isosorbide dinitrate in patients with coronary heart disease.口服高剂量硝酸异山梨酯对冠心病患者的持续抗心绞痛疗效。
Z Kardiol. 1983;72 Suppl 3:259-67.